Advances in Pharmacoeconomics
Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of health economics. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life) of a pharmaceutical product. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.
Components of the Book:
  • Chapter 1
    Cost Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT
  • Chapter 2
    Mapping Dermatology Life Quality Index (DLQI) scores to EQ 5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study
  • Chapter 3
    Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature
  • Chapter 4
    Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
  • Chapter 5
    Predictors of negotiated prices for new drugs in Germany
  • Chapter 6
    The excess economic burden of mental disorders: findings from a cross sectional prevalence survey in Austria
  • Chapter 6
    The excess economic burden of mental disorders: findings from a cross sectional prevalence survey in Austria
  • Chapter 6
    The excess economic burden of mental disorders: findings from a cross sectional prevalence survey in Austria
  • Chapter 9
    Lebanese pharmacists’ confidence and selfperceptions of computer literacy: scale validation and correlates
  • Chapter 9
    Lebanese pharmacists’ confidence and selfperceptions of computer literacy: scale validation and correlates
  • Chapter 11
    Impact of a global leader on pharmaceutical practice and policy around the world
  • Chapter 12
    Randomized double-blind clinical trial comparing safety and efficacy of the biosimilar BCD-022 with reference trastuzumab
  • Chapter 13
    Pharmacy students’ attitudes toward patient safety in Saudi Arabia: a crosssectional study
  • Chapter 14
    Compliance with the north American Society of Pacing and Electrophysiology guidelines on amiodarone monitoring in Riyadh, Saudi Arabia: a retrospective charts review study
  • Chapter 15
    Patient and health system costs of managing pregnancy and birth-related complications in sub-Saharan Africa: a systematic review
  • Chapter 16
    Factors associated with empathy among community pharmacists in Lebanon
Readership: Students, academics, teachers and other people attending or interested in Pharmacoeconomics .
William Hollingworth
William Hollingworth, Bristol Medical School, University of Bristol, 5 Tyndall Avenue, Bristol, BS8 1UD, UK

Cathrine Elgaard Jensen
Cathrine Elgaard Jensen, Department of Clinical Medicine, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark

Klas Kellerborg
Klas Kellerborg, Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands

Raju Kandimalla
Raju Kandimalla, Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, TX, USA

Afschin Gandjour
Afschin Gandjour, Frankfurt School of Finance and Management, Frankfurt am Main, Germany

Agata Łaszewska
Agata ?aszewska, Department of Health Economics, Center for Public Health, Medical University of Vienna, Kinderspitalgasse 15/I, 1090, Vienna, Austria

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top